Foghorn Therapeutics Inc. Common Stock

FHTXNASDAQUSD
5.31 USD
0.12 (2.31%)AT CLOSE (11:59 AM EDT)
5.31
0.00 (0.02%)
POST MARKET (AS OF 06:02 PM EDT)
Post Market
AS OF 06:02 PM EDT
5.31
0.00 (0.02%)
🔴Market: CLOSED
Open?$5.17
High?$5.38
Low?$5.10
Prev. Close?$5.19
Volume?81.1K
Avg. Volume?153.3K
VWAP?$5.28
Rel. Volume?0.53x
Bid / Ask
Bid?$4.51 × 100
Ask?$6.04 × 100
Spread?$1.53
Midpoint?$5.28
Valuation & Ratios
Market Cap?311.7M
Shares Out?58.7M
Float?34.4M
Float %?60.9%
P/E Ratio?N/A
P/B Ratio?-2.87
EPS?-$1.27
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.71Strong
Quick Ratio?2.71Strong
Cash Ratio?1.35Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A
P/B?
-2.87CHEAP
P/S?
10.08HIGH
P/FCF?
N/A
EV/EBITDA?
-3.0CHEAP
EV/Sales?
7.47HIGH
Returns & Efficiency
ROE?
68.5%STRONG
ROA?
-37.5%WEAK
Cash Flow & Enterprise
FCF?$-86149000
Enterprise Value?$230.8M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Employees
106
Market Cap
311.7M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-10-23
Address
500 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
Phone: 617-586-3100